• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒感染与心血管疾病:对 COVID-19 发病机制分子基础的影响。

Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.

机构信息

College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Erie, PA 16509, USA.

Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC 20007, USA.

出版信息

Int J Mol Sci. 2021 Feb 7;22(4):1659. doi: 10.3390/ijms22041659.

DOI:10.3390/ijms22041659
PMID:33562193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7914972/
Abstract

The current pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While this respiratory virus only causes mild symptoms in younger healthy individuals, elderly people and those with cardiovascular diseases such as systemic hypertension are susceptible to developing severe conditions that can be fatal. SARS-CoV-2 infection is also associated with an increased incidence of cardiovascular diseases such as myocardial injury, acute coronary syndrome, and thromboembolism. Understanding the mechanisms of the effects of this virus on the cardiovascular system should thus help develop therapeutic strategies to reduce the mortality and morbidity associated with SARS-CoV-2 infection. Since this virus causes severe and fatal conditions in older individuals with cardiovascular comorbidities, effective therapies targeting specific populations will likely contribute to ending this pandemic. In this review article, the effects of various viruses-including other coronaviruses, influenza, dengue, and human immunodeficiency virus-on the cardiovascular system are described to help provide molecular mechanisms of pathologies associated with SARS-CoV-2 infection and COVID-19. The goal is to provide mechanistic information from the biology of other viral infections in relation to cardiovascular pathologies for the purpose of developing improved vaccines and therapeutic agents effective in preventing and/or treating the acute and long-term consequences of SARS-CoV-2 and COVID-19.

摘要

当前 2019 年冠状病毒病(COVID-19)大流行是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的。虽然这种呼吸道病毒在年轻健康个体中仅引起轻微症状,但老年人和患有心血管疾病(如系统性高血压)的人易发生可能致命的严重情况。SARS-CoV-2 感染也与心血管疾病的发病率增加有关,如心肌损伤、急性冠状动脉综合征和血栓栓塞。因此,了解这种病毒对心血管系统的影响机制应有助于制定治疗策略,以降低与 SARS-CoV-2 感染相关的死亡率和发病率。由于这种病毒会导致患有心血管合并症的老年个体出现严重和致命的情况,因此针对特定人群的有效疗法可能有助于结束这一大流行。在这篇综述文章中,描述了包括其他冠状病毒、流感、登革热和人类免疫缺陷病毒在内的各种病毒对心血管系统的影响,以帮助提供与 SARS-CoV-2 感染和 COVID-19 相关的病理学的分子机制。目的是提供其他病毒感染的生物学方面与心血管病理学相关的机制信息,以便开发有效的疫苗和治疗剂,预防和/或治疗 SARS-CoV-2 和 COVID-19 的急性和长期后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a5/7914972/4a8e58d991a2/ijms-22-01659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a5/7914972/2ea7ed9e8353/ijms-22-01659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a5/7914972/c8de24f9f91d/ijms-22-01659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a5/7914972/56d46f30379c/ijms-22-01659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a5/7914972/4a8e58d991a2/ijms-22-01659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a5/7914972/2ea7ed9e8353/ijms-22-01659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a5/7914972/c8de24f9f91d/ijms-22-01659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a5/7914972/56d46f30379c/ijms-22-01659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a5/7914972/4a8e58d991a2/ijms-22-01659-g004.jpg

相似文献

1
Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.病毒感染与心血管疾病:对 COVID-19 发病机制分子基础的影响。
Int J Mol Sci. 2021 Feb 7;22(4):1659. doi: 10.3390/ijms22041659.
2
The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.COVID-19 中的心血管疾病与预后性心生物标志物。
Mol Biol Rep. 2021 Feb;48(2):1763-1771. doi: 10.1007/s11033-021-06148-9. Epub 2021 Jan 22.
3
Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.SARS-COV-2 刺突糖蛋白的优化假型条件。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.01062-20.
4
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.基于 SARS-CoV-2 刺突糖蛋白与 ACE-2 受体同源物和人类 TLR 相互作用的比较特征的计算机研究。
J Med Virol. 2020 Oct;92(10):2105-2113. doi: 10.1002/jmv.25987. Epub 2020 May 17.
5
Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.严重急性呼吸综合征冠状病毒2的潜在发病机制。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):591-597. doi: 10.11817/j.issn.1672-7347.2020.200299.
6
ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.ACE2:其在严重急性呼吸综合征和 COVID-19 中的潜在作用和调控。
J Cell Physiol. 2021 Apr;236(4):2430-2442. doi: 10.1002/jcp.30041. Epub 2020 Sep 9.
7
Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.血小板-内皮细胞相互作用在严重 SARS-CoV-2 感染相关心肌损伤发病机制中的新作用。
Front Immunol. 2022 Feb 4;13:776861. doi: 10.3389/fimmu.2022.776861. eCollection 2022.
8
Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.基于 SARS-CoV-2 刺突蛋白/血管紧张素转化酶 2 复合物的丙氨酸扫描计算和结构分析。
ACS Nano. 2020 Sep 22;14(9):11821-11830. doi: 10.1021/acsnano.0c04674. Epub 2020 Aug 26.
9
ACE2 role in SARS-CoV-2 infectivity and Covid-19 severity.ACE2 在 SARS-CoV-2 感染性和 COVID-19 严重性中的作用。
Malays J Pathol. 2020 Dec;42(3):363-367.
10
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.

引用本文的文献

1
Immunoexpression of placental growth factor (PlGF) and soluble FMS-like tyrosine kinase 1 (sFlt-1) in the placental bed of preeclamptic women of African ancestry living with HIV infection.免疫组化法检测非洲裔 HIV 感染子痫前期患者胎盘床组织中胎盘生长因子(PlGF)和可溶性 FMS 样酪氨酸激酶 1(sFlt-1)的表达
Histochem Cell Biol. 2024 Nov 23;163(1):8. doi: 10.1007/s00418-024-02341-6.
2
Anti-SARS-CoV-2 Antibodies versus Vaccination Status in CAD Patients with COVID-19: A Prospective, Propensity Score-Matched Cohort Study.新冠病毒感染冠心病患者中抗SARS-CoV-2抗体与疫苗接种状态的关系:一项前瞻性、倾向评分匹配队列研究
Vaccines (Basel). 2024 Jul 30;12(8):855. doi: 10.3390/vaccines12080855.
3

本文引用的文献

1
MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges.MERS-CoV:流行病学、分子动力学、治疗学及未来挑战。
Ann Clin Microbiol Antimicrob. 2021 Jan 18;20(1):8. doi: 10.1186/s12941-020-00414-7.
2
SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines.严重急性呼吸综合征冠状病毒2刺突蛋白在人类宿主细胞中引发细胞信号传导:对2019冠状病毒病疫苗可能后果的影响
Vaccines (Basel). 2021 Jan 11;9(1):36. doi: 10.3390/vaccines9010036.
3
The viral protein fragment theory of COVID-19 pathogenesis.
Extracellular vesicles and endothelial dysfunction in infectious diseases.
传染病中的细胞外囊泡与内皮功能障碍
J Extracell Biol. 2024 Apr 12;3(4):e148. doi: 10.1002/jex2.148. eCollection 2024 Apr.
4
Effects of spike proteins on angiotensin converting enzyme 2 (ACE2).刺突蛋白对血管紧张素转化酶 2(ACE2)的影响。
Arch Biochem Biophys. 2023 Oct 15;748:109769. doi: 10.1016/j.abb.2023.109769. Epub 2023 Sep 27.
5
A systematic review and meta-analysis on the prevalence and impact of coronary artery disease in hospitalized COVID-19 patients.关于住院COVID-19患者冠状动脉疾病患病率及影响的系统评价和荟萃分析。
Heliyon. 2023 Aug 25;9(9):e19493. doi: 10.1016/j.heliyon.2023.e19493. eCollection 2023 Sep.
6
Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis.mRNA COVID-19 疫苗接种和未接种人群中心肌炎和心包炎的风险:系统评价和荟萃分析。
BMJ Open. 2023 Jun 20;13(6):e065687. doi: 10.1136/bmjopen-2022-065687.
7
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review.动脉粥样硬化、心血管疾病与2019冠状病毒病:一篇叙述性综述
Biomedicines. 2023 Apr 18;11(4):1206. doi: 10.3390/biomedicines11041206.
8
Cardiovascular Diseases-A Focus on Atherosclerosis, Its Prophylaxis, Complications and Recent Advancements in Therapies.心血管疾病——聚焦动脉粥样硬化、其预防、并发症以及治疗的最新进展。
Int J Mol Sci. 2022 Apr 23;23(9):4695. doi: 10.3390/ijms23094695.
9
COVID-Related Athletic Deaths: Another Perfect Storm?与新冠病毒相关的运动员死亡事件:又一场完美风暴?
Front Sports Act Living. 2022 Apr 12;4:829093. doi: 10.3389/fspor.2022.829093. eCollection 2022.
10
Cardiovascular System during SARS-CoV-2 Infection.心血管系统在 SARS-CoV-2 感染期间的变化。
Int J Environ Res Public Health. 2022 Jan 21;19(3):1184. doi: 10.3390/ijerph19031184.
新冠病毒发病机制的病毒蛋白片段理论。
Med Hypotheses. 2020 Nov;144:110267. doi: 10.1016/j.mehy.2020.110267. Epub 2020 Sep 11.
4
SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.SARS-CoV-2 刺突蛋白介导的肺血管细胞中的细胞信号转导。
Vascul Pharmacol. 2021 Apr;137:106823. doi: 10.1016/j.vph.2020.106823. Epub 2020 Nov 21.
5
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.从 SARS 和 MERS 到 COVID-19:三种高致病性人冠状病毒引起的严重急性呼吸道感染的简要总结和比较。
Respir Res. 2020 Aug 27;21(1):224. doi: 10.1186/s12931-020-01479-w.
6
Coronavirus Disease of 2019: a Mimicker of Dengue Infection?2019冠状病毒病:登革热感染的模仿者?
SN Compr Clin Med. 2020;2(8):1109-1119. doi: 10.1007/s42399-020-00364-3. Epub 2020 Jul 13.
7
A Critical Role for Perivascular Cells in Amplifying Vascular Leakage Induced by Dengue Virus Nonstructural Protein 1.血管周细胞在登革病毒非结构蛋白 1 诱导的血管渗漏中起关键作用。
mSphere. 2020 Aug 5;5(4):e00258-20. doi: 10.1128/mSphere.00258-20.
8
Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.SARS-CoV 和 SARS-CoV-2 的差异和相似性:刺突受体结合域识别和细胞丝氨酸蛋白酶辅助的宿主细胞感染。
Infection. 2020 Oct;48(5):665-669. doi: 10.1007/s15010-020-01486-5. Epub 2020 Jul 31.
9
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.新型冠状病毒肺炎与心血管疾病:从基础机制到临床展望。
Nat Rev Cardiol. 2020 Sep;17(9):543-558. doi: 10.1038/s41569-020-0413-9. Epub 2020 Jul 20.
10
Severe COVID-19: NLRP3 Inflammasome Dysregulated.严重 COVID-19:NLRP3 炎性小体失调。
Front Immunol. 2020 Jun 26;11:1580. doi: 10.3389/fimmu.2020.01580. eCollection 2020.